BIOTEST AG (BIO.DE) Stock Balance Sheet
FRA:BIO - Deutsche Boerse Ag - DE0005227201 - Common Stock - Currency: EUR
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | 108.10M | 116.60M | 104.50M | 71.30M | |||
| Cash Equivalents | 24.70M | N/A | N/A | -100.00K | N/A | |||
| Marketable Securities | 13.10M | N/A | 27.00M | 13.20M | 19.30M | |||
| Receivables | 171.80M | 205.00M | 163.60M | 150.50M | 167.00M | |||
| Inventories | 487.60M | 419.10M | 293.80M | 244.60M | 290.10M | |||
| Other Current Assets | 7.30M | 24.30M | 18.40M | 9.50M | 8.60M | |||
| Total Current Assets | 704.50M | 756.50M | 619.40M | 522.20M | 556.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 573.90M | 578.40M | 547.80M | 550.00M | 548.30M | |||
| Investments And Advances | 26.50M | 11.40M | 5.20M | 4.60M | 2.80M | |||
| Goodwill | N/A | 6.00M | 7.20M | 7.00M | 7.10M | |||
| Intangibles | 16.40M | 9.00M | 9.20M | 4.30M | 6.90M | |||
| Other Non-Current Assets | 25.40M | 33.00M | 1.00M | 10.60M | 9.90M | |||
| Total Non-Current Assets | 642.20M | 654.40M | 583.60M | 582.00M | 575.00M | |||
| TOTAL ASSETS | 1.35B | 1.41B | 1.20B | 1.10B | 1.13B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 181.90M | 260.00M | 31.10M | 34.30M | 7.90M | |||
| Accounts Payable | 58.10M | 78.10M | 51.10M | 38.80M | 42.00M | |||
| Other Current Liabilities | 37.10M | 47.20M | 48.00M | 33.30M | 55.70M | |||
| Total Current Liabilities | 277.10M | 385.30M | 130.20M | 106.40M | 105.60M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 432.00M | 429.70M | 612.80M | 495.30M | 461.20M | |||
| Deferred Taxes/Income | 1.10M | 1.10M | 1.20M | 2.20M | 1.20M | |||
| Other Non-Current Liabilities | 109.00M | 95.90M | 87.70M | 119.90M | 121.70M | |||
| Total Non-Current Liabilities | 542.10M | 526.70M | 701.70M | 617.40M | 584.10M | |||
| TOTAL LIABILITIES | 819.20M | 912.00M | 831.90M | 723.80M | 689.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | 268.10M | 249.90M | 111.70M | 153.70M | 185.10M | |||
| Additional Paid In Capital | 219.80M | 219.80M | 219.80M | 219.80M | 219.80M | |||
| Minority Interest | N/A | N/A | N/A | N/A | N/A | |||
| Common Shares | 39.60M | 39.60M | 39.60M | 39.60M | 39.60M | |||
| Other Shareholders' Equity | N/A | -10.40M | N/A | -32.70M | -2.90M | |||
| Shares Outstanding | 39.57M | 39.57M | 39.57M | 39.57M | 19.79M | |||
| Tangible Book Value per Share | 12.92 | 12.23 | 8.96 | 9.33 | 21.61 | |||
| Total Shareholders' Equity | 527.50M | 498.90M | 371.10M | 380.40M | 441.60M | |||
| TOTAL LIABILITIES AND EQUITY | 1.35B | 1.41B | 1.20B | 1.10B | 1.13B | |||
| Statistics | ||||||||
| Debt/Equity | 0.82 | 0.86 | 1.65 | 1.30 | 1.04 | |||
| Current Ratio | 2.54 | 1.96 | 4.76 | 4.91 | 5.27 | |||
| Return On Assets (ROA) | 5.09% | 9.00% | -2.70% | -5.89% | -2.84% | |||
| Return On Equity (ROE) | 12.99% | 25.46% | -8.76% | -17.08% | -7.29% | |||
| Return On Invested Capital (ROIC) | 5.87% | 8.26% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | 6.09% | 8.26% | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexcg) | 6.18% | 8.38% | N/A | N/A | N/A | |||
All data in EUR , ROIC based on taxRate of 0.30